Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre-Reference-Cited by-同舟云学术

Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre

Published:2022-10-07 Issue:5 Volume:12 Page:5255-5264
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Stares Mark¹²^ORCID,Chauhan Vishwani²,Moudgil‐Joshi Jigi²,Kong Qiu G.²,Malik Jahangeer¹,Sundaramurthy Aravindhan¹,Elliott Tony¹,Mains Edward³,Leung Steve³,Laird Alexander³,Symeonides Stefan N.¹²

Affiliation:

1. Edinburgh Cancer Centre Western General Hospital, NHS Lothian Edinburgh UK

2. Institute of Genetics and Cancer Cancer Research UK Edinburgh Centre, University of Edinburgh Edinburgh UK

3. Department of Urology Western General Hospital, NHS Lothian Edinburgh UK

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5330

Reference36 articles.

1. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

2. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

3. Observation as a treatment strategy for advanced renal cell carcinoma—a call for prospective validation

4. Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

5. Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review;Future Oncology;2024-09-11

2. Active Surveillance in Metastatic Renal Cell Carcinoma;Journal of Kidney Cancer and VHL;2024-06-04

3. Biomarkers of systemic inflammation provide additional prognostic stratification in cancers of unknown primary;Cancer Medicine;2024-02

4. Is there an Association between Lymph Node Size and Hyperprogression in Immunotherapy-Treated Patients?;Romanian Journal of Internal Medicine;2023-10-26